Home
CATX
CATX News

Latest Perspective Therapeutics Inc. (CATX) News on July 27, 2024

MT Newswires

2 days ago

BofA Securities Starts Perspective Therapeutics With Buy Rating, $24 Price Target

Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results

GlobeNewswire

5 days ago

Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results

Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet

Zacks

10 days ago

Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet

MT Newswires

a month ago

Sector Update: Health Care Stocks Softer Wednesday Afternoon

MT Newswires

a month ago

Perspective Therapeutics to Join Russell 3000 Index on July 1

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index

GlobeNewswire

a month ago

Perspective Therapeutics Announces Inclusion in the Russell 3000® Index

MT Newswires

2 months ago

Perspective Therapeutics to Reverse Split Common Shares

Perspective Therapeutics Announces 1-for-10 Reverse Stock Split

GlobeNewswire

2 months ago

Perspective Therapeutics Announces 1-for-10 Reverse Stock Split

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

GlobeNewswire

2 months ago

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting

MT Newswires

2 months ago

Perspective Therapeutics Prices $80 Million Share, Warrant Offering

Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

2 months ago

Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024

GlobeNewswire

2 months ago

Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024

MT Newswires

2 months ago

Perspective Therapeutics Swings to Loss in Q1, Revenue Rises

Associated Press Finance

2 months ago

Perspective Therapeutics: Q1 Earnings Snapshot

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results

GlobeNewswire

2 months ago

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results

Perspective Therapeutics to Participate at Upcoming May Investor Conferences

GlobeNewswire

3 months ago

Perspective Therapeutics to Participate at Upcoming May Investor Conferences

GuruFocus.com

3 months ago

Lantheus Holdings Inc (LNTH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...

Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results

GlobeNewswire

3 months ago

Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results

Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs

GlobeNewswire

3 months ago

Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs

Perspective Therapeutics to Participate at Upcoming April Investor Conferences

GlobeNewswire

4 months ago

Perspective Therapeutics to Participate at Upcoming April Investor Conferences

Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results

GuruFocus.com

4 months ago

Perspective Therapeutics Inc (CATX) Reports Fiscal Year 2023 Financial Results

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

GlobeNewswire

4 months ago

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results

Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal

The Wall Street Journal

4 months ago

Heard on the Street: Pharma Goes Radioactive as AstraZeneca Announces Fusion Deal

Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma

GlobeNewswire

4 months ago

Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma

Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024

GlobeNewswire

5 months ago

Perspective Therapeutics to Host In-Person and Virtual Analyst Day to Discuss Targeted Alpha-Particle Radiotherapy for Cancer on March 18, 2024

Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility

GlobeNewswire

5 months ago

Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility

Perspective Therapeutics Announces $87.4 Million Private Placement

GlobeNewswire

5 months ago

Perspective Therapeutics Announces $87.4 Million Private Placement

Perspective Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire

5 months ago

Perspective Therapeutics to Participate at Upcoming Investor Conferences

These Drug Companies Are Going Nuclear to Fight Cancer

The Wall Street Journal

5 months ago

These Drug Companies Are Going Nuclear to Fight Cancer

PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth

Zacks

5 months ago

PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth

Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire

5 months ago

Perspective Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline

Zacks

6 months ago

Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline

Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform

GlobeNewswire

6 months ago

Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

Zacks

6 months ago

Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?

Associated Press Finance

6 months ago

Financial Institutions: Q4 Earnings Snapshot

GuruFocus.com

6 months ago

Financial Institutions Inc (FISI) Reports Mixed Results Amidst Challenging Interest Rate Environment

Financial Institutions, Inc. Announces Fourth Quarter and Full Year 2023 Results

GlobeNewswire

6 months ago

Financial Institutions, Inc. Announces Fourth Quarter and Full Year 2023 Results

There's More to Restaurants Brands International's $1 Billion Acquisition Than Meets the Eye

Motley Fool

6 months ago

There's More to Restaurants Brands International's $1 Billion Acquisition Than Meets the Eye

XAI Octagon Floating Rate & Alternative Income Term Trust Announces Shareholder Approval of Important Proposals

Business Wire

6 months ago

XAI Octagon Floating Rate & Alternative Income Term Trust Announces Shareholder Approval of Important Proposals

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement

GlobeNewswire

6 months ago

Perspective Therapeutics Announces Closing of $69.0 Million Public Offering and $20.8 Million Private Placement

Potbelly Launches Reimagined Potbelly Perks Loyalty Program

PR Newswire

6 months ago

Potbelly Launches Reimagined Potbelly Perks Loyalty Program

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement

GlobeNewswire

6 months ago

Perspective Therapeutics Announces Pricing of $60.0 Million Public Offering And $20.8 Million Private Placement

Perspective Therapeutics Announces Proposed Public Offering

GlobeNewswire

6 months ago

Perspective Therapeutics Announces Proposed Public Offering

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

GlobeNewswire

6 months ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Loss-Making iHeartMedia, Inc. (NASDAQ:IHRT) Set To Breakeven

Simply Wall St.

6 months ago

Loss-Making iHeartMedia, Inc. (NASDAQ:IHRT) Set To Breakeven

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

GlobeNewswire

7 months ago

Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

GlobeNewswire

7 months ago

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability

DocGo Subsidiary Achieves ISO 9001:2015 Certification, Further Elevating its Commitment to Quality Management

Business Wire

7 months ago

DocGo Subsidiary Achieves ISO 9001:2015 Certification, Further Elevating its Commitment to Quality Management

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

GlobeNewswire

7 months ago

Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024

First Bank Announces Fourth Quarter 2023 Earnings Conference Call

GlobeNewswire

7 months ago

First Bank Announces Fourth Quarter 2023 Earnings Conference Call

Wallbox Announces Upcoming Events for the Investor Community

Business Wire

7 months ago

Wallbox Announces Upcoming Events for the Investor Community

With 77% ownership, Priority Technology Holdings, Inc. (NASDAQ:PRTH) insiders have a lot at stake

Simply Wall St.

7 months ago

With 77% ownership, Priority Technology Holdings, Inc. (NASDAQ:PRTH) insiders have a lot at stake

12 Most Profitable Pot Stocks Now

Insider Monkey

7 months ago

12 Most Profitable Pot Stocks Now

Priority Announces Strategic Technology Partnership with Treasure Financial

Business Wire

8 months ago

Priority Announces Strategic Technology Partnership with Treasure Financial

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

Business Wire

8 months ago

KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update

Gannett Joins LOT Network to Protect Digital Asset Products from Patent Litigation

Business Wire

8 months ago

Gannett Joins LOT Network to Protect Digital Asset Products from Patent Litigation

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

GlobeNewswire

8 months ago

Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

Investing $4,000 in These 4 Top Stocks Might Make You Rich

Motley Fool

8 months ago

Investing $4,000 in These 4 Top Stocks Might Make You Rich

Belpointe OZ Announces Third Quarter Net Asset Value Per Class A Unit of $103.50

GlobeNewswire

8 months ago

Belpointe OZ Announces Third Quarter Net Asset Value Per Class A Unit of $103.50

Humacyte Third Quarter 2023 Financial Results and Business Update

GlobeNewswire

9 months ago

Humacyte Third Quarter 2023 Financial Results and Business Update

Saba Capital Management, L.P. Increases Stake in ASA Gold And Precious Metals Ltd

GuruFocus.com

9 months ago

Saba Capital Management, L.P. Increases Stake in ASA Gold And Precious Metals Ltd

Share on Social Networks: